These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Infantile nephrotic syndrome and congenital glaucoma. Kari JA; Bamashmous H; Lingawi S; Al-Sabban E; Akhtar M Pediatr Nephrol; 2001 Nov; 16(11):894-7. PubMed ID: 11685596 [TBL] [Abstract][Full Text] [Related]
6. Different renal pathologies associated with hypothyroidism. Paydas S; Gokel Y Ren Fail; 2002 Sep; 24(5):595-600. PubMed ID: 12380904 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of cyclosporin A efficacy in the treatment of steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis--case report]. Zelichowski G; Nowosławski A; Wawer Z; Wańkowicz Z Pol Arch Med Wewn; 2001 Nov; 106(5):1065-9. PubMed ID: 12026521 [TBL] [Abstract][Full Text] [Related]
8. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases. Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171 [TBL] [Abstract][Full Text] [Related]
9. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease. Menegato MA; Canelles MF; Tonutti E; Pizzolitto S Clin Nephrol; 2004 May; 61(5):352-6. PubMed ID: 15182131 [TBL] [Abstract][Full Text] [Related]
10. [Rapidly progressing glomerulonephritis developing against a background of idiopathic nephrotic syndrome]. Monova D; Belovezhdov N; Minova V; Doĭchinov D Vutr Boles; 1988; 27(6):100-3. PubMed ID: 3247697 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions. Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208 [TBL] [Abstract][Full Text] [Related]
12. Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome. Erem C; Algün E; Ozbey N; Azezli A; Aral F; Orhan Y; Molvalilar S; Sencer E J Endocrinol Invest; 2003 Jan; 26(1):65-72. PubMed ID: 12602537 [TBL] [Abstract][Full Text] [Related]
13. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
14. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis. Sugimoto T; Ito J; Takeda N; Gasyu I; Okazaki T; Sakaguchi M; Osawa N; Tanaka Y; Oka K; Uzu T; Kashiwagi A Am J Med Sci; 2008 Jun; 335(6):495-8. PubMed ID: 18552583 [TBL] [Abstract][Full Text] [Related]
15. [Glomerular kidney disease that is associated with nephrotic syndrome or rapidly advancing renal failure]. Okoń K Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s48-56. PubMed ID: 23120831 [No Abstract] [Full Text] [Related]
16. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival. de Paula LC; Mazzali M; de Sousa MV Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201 [TBL] [Abstract][Full Text] [Related]